Ascriptin (Aspirin)

Quick links to important sections

Ascriptin (Aspirin)

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ascriptin (Aspirin)

What is Ascriptin (Aspirin)?

Ascriptin is a brand-name formulation of aspirin, a medication belonging to the class of drugs known as salicylates. It is primarily used for its analgesic (pain-relieving), antipyretic (fever-reducing), and anti-inflammatory properties.

Composition and Mechanism

The distinguishing feature of Ascriptin is that it combines aspirin with antacids, such as magnesium hydroxide, aluminum hydroxide, and calcium carbonate. This combination is designed to help buffer the acidic nature of aspirin, potentially reducing the localized irritation to the stomach lining that can occur with standard aspirin tablets.

Aspirin works by inhibiting the production of prostaglandins, which are chemicals in the body that signal pain and trigger inflammation. It also acts as a platelete-aggregation inhibitor, meaning it interferes with the blood's ability to clump together and form clots.

Common Uses

Ascriptin is utilized in various clinical and over-the-counter contexts for the management of mild to moderate discomfort and specific chronic conditions:

  • Pain Relief: It is used to alleviate headaches, muscle aches, dental pain, and menstrual cramps.
  • Fever Reduction: It is employed to temporarily reduce body temperature during febrile illnesses.
  • Inflammatory Conditions: It is often used to manage symptoms of inflammatory disorders, such as rheumatoid arthritis, osteoarthritis, and other rheumatic conditions.
  • Cardiovascular Support: Due to its blood-thinning properties, it is frequently used in long-term therapy to reduce the risk of specific cardiovascular events in individuals with a high risk of clot-related issues.

Regulatory References

  1. World Health Organization
  2. WHO Model Lists of Essential Medicines

What side effects are possible with Ascriptin (Aspirin)?

Possible Side Effects and Safety Information

The official safety profile for Acetylsalicylic acid (ASA), the active ingredient in Ascriptin, is organized by regulatory agencies based on frequency and the body system affected. The primary safety concerns are related to bleeding risk, gastrointestinal effects, and specific population vulnerabilities.

Adverse Reaction Scope

Category Description based on Official Regulatory Documentation
Key adverse reaction categories Bleeding events (hemorrhagic syndromes), gastrointestinal effects (ulceration, dyspepsia), and hypersensitivity reactions (anaphylaxis, bronchospasm).
Frequency classification Common (e.g., minor gastrointestinal microbleeds, dyspepsia); Rare (e.g., major hemorrhage, anaphylactic reaction); Frequency Not Known (e.g., tinnitus, hearing impairment).
System-organ classes involved Gastrointestinal Disorders, Blood and Lymphatic System Disorders, Immune System Disorders, and Nervous System Disorders.

Serious Adverse Reactions and Safety Constraints

Serious adverse reactions documented in regulatory labeling include Major Gastrointestinal Hemorrhage and Reye's Syndrome, the latter specifically associated with use in children and adolescents recovering from viral illnesses. The medicine's effect on increased bleeding time persists for approximately four to eight days after the last dose, and the risk of serious gastrointestinal events increases with the duration of use.

Population-specific safety notes include an increased risk of bleeding in older adults and the medicine is generally contraindicated in the third trimester of pregnancy and in patients with severe hepatic or renal failure.

These safety classifications structure the understanding of the medicine's risks by establishing that the consequences of its antiplatelet activity and NSAID properties are the most serious, documented concerns, which are also influenced by patient-specific vulnerabilities.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for Acetylsalicylic acid (Aspirin) establishes clear criteria for emergency medical intervention. Immediate medical attention is required for any suspected overdose or upon the onset of initial signs of Salicylism. It is mandated to contact a Poison Control Center immediately for any known or suspected ingestion exceeding recommended levels.

Documented Overdose Manifestations

Clinical signs documented in official labeling may include tinnitus (ringing in the ears), persistent nausea, vomiting, hyperventilation (rapid or deep breathing), sweating, headache, and dizziness. Severe, life-threatening outcomes officially documented include the development of profound metabolic acidosis, non-cardiogenic pulmonary edema, cerebral edema, seizures, acute renal failure, and potential cardiovascular collapse.

Regulatory Management and Monitoring

The management strategy described in regulatory documents is purely supportive, as no specific antidote is known. Documented procedures include the administration of activated charcoal, aggressive intravenous fluid resuscitation, and urinary alkalinisation using sodium bicarbonate to enhance drug elimination. Hospital monitoring is required for suspected toxic ingestions, involving serial checks of serum salicylate levels and continuous monitoring of the patient's acid-base status.

Population-specific warnings are noted for children, who are more susceptible to severe metabolic acidosis, and the elderly, who face increased risk due to chronic intoxication.

Therapeutic Uses of Ascriptin (Aspirin)

What Ascriptin (Aspirin) Treats: Main Uses and Benefits

Ascriptin (Aspirin) is used across therapeutic domains where short-term symptomatic assistance and supportive relief are appropriate, particularly when symptoms create noticeable interference with daily stability. The medication provides support that helps ease the overall burden of symptoms that may appear suddenly or intensify over time. This medicine is commonly used to help with a range of conditions presenting with acute or episodic manifestations.

Symptom Domains and Benefits

Ascriptin is applied in clinical settings marked by heightened patient distress to address symptom clusters related to acute pain, fever, and discomfort associated with inflammatory states. It is commonly used to help with symptoms such as headache, muscle aches, and mild joint pain. For patients, this use contributes to improved day-to-day comfort and helps them cope more steadily with difficult episodes.

Under medical supervision, low-dose Aspirin is also relevant when supportive symptom management is appropriate in situations where symptoms form part of acute or recurrent episodes related to blood vessel blockages. The supportive use is relevant when managing symptoms associated with vascular stress, assisting with maintaining functional stability in high-risk patients.

Quick Fact: Relief for Acute Discomfort and Symptom Clusters

Regulatory References

  1. NIH MedlinePlus overview of Aspirin

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Ascriptin (Aspirin) — Official Regulatory Information

Populations for whom use is contraindicated:

  • Patients with known hypersensitivity to Acetylsalicylic acid (ASA), other salicylates, or other NSAIDs.
  • Patients with active peptic ulcer or a history of recurrent gastrointestinal bleeding/ulcers.
  • Patients with severe hepatic insufficiency (liver), severe renal insufficiency (kidney), or severe uncontrolled cardiac insufficiency.
  • Patients in the third trimester of pregnancy (for standard/high doses).

Age-related eligibility rules:

  • Pediatric (Under 16): Use is generally not recommended for children and adolescents due to the regulatory warning regarding the risk of Reye's Syndrome, especially during viral illnesses.
  • Adults (16+): Eligible for standard use.
  • Older Adults (Geriatric): Eligible, but designated as a cautionary population due to increased susceptibility to gastrointestinal bleeding.

Pregnancy and lactation eligibility status:

  • Pregnancy: Use is prohibited in the third trimester. However, low-dose ASA is specifically permitted and often prescribed for high-risk conditions like pre-eclampsia.
  • Lactation: Use is not recommended by some regulatory sources for regular or high doses.

The regulatory documents establish eligibility by strictly classifying populations based on high physiological risk, such as severe organ failure, bleeding disorders, and life stage. These classifications enforce clear exclusions and conditional use guidelines to manage safety within the labeled population.

What should I know about interactions with other medicines?

Ascriptin (Aspirin) Interactions with other medicines and products

The following interaction information for Acetylsalicylic acid (ASA), the active ingredient in Ascriptin, is strictly based on official regulatory documents. This section identifies substances that are documented to interact with ASA.

Formal Contraindicated Combinations

Interacting Substance Official Restriction
Methotrexate (at doses >15 mg/week) Contraindicated due to risk of increased toxicity.
Oral Anticoagulants (e.g., Warfarin) Contraindicated in patients with a history of gastro-duodenal ulcers.

Key Documented Interactions

Interactions primarily relate to additive bleeding risk and altered exposure of co-administered medicines.

  • Other Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Concomitant use with other NSAIDs is officially documented to increase the risk of gastrointestinal ulcers and bleeding.
  • Anticoagulants / Anti-platelet Agents: Co-administration with agents such as heparin, LMWH, or clopidogrel is documented to significantly increase the risk of haemorrhage.
  • Diuretics & Antihypertensives: ASA is documented to reduce the efficacy of these medicines, including ACE inhibitors, due to effects on renal function.
  • Digoxin and Lithium: ASA is documented to increase the plasma concentrations of both medicines by reducing their renal clearance.
  • Alcohol: Consumption of alcohol is documented to substantially increase the risk of gastrointestinal bleeding.

⏱️ Timing and Population Notes

The label notes that timing separation may be required for occasional Ibuprofen use to avoid interference with the antiplatelet effect of low-dose aspirin. Increased haemorrhage risk is noted for Elderly Patients co-administering with certain heparin products.

Mechanism of Action

How Ascriptin (Aspirin) Works

Irreversible Inhibition of COX Enzymes

The primary mechanism of Acetylsalicylic acid (ASA) involves the irreversible deactivation of Cyclooxygenase (COX) enzymes ( COX-1 and COX-2) throughout the body. This permanent binding blocks the initial molecular step in the Arachidonic Acid Cascade, profoundly suppressing the synthesis of Prostaglandins ( PGE2) and other inflammatory mediators. This action modulates chemical signaling that contributes to nociceptor sensitization and modulates the vascular components (vasodilation and increased capillary permeability) of the inflammatory response.

Central and Peripheral Pathway Modulation

The ASA mechanism is relevant in two distinct signaling systems: the peripheral nerves and the central hypothalamus. By suppressing PGE2 in the hypothalamus, the drug targets the regulatory center that controls core body temperature, leading to the activation of heat-loss mechanisms. Simultaneously, reduced PGE2 in peripheral tissues reduces the sensitization of pain-sensing nerve fibers (nociceptors).

Sustained Antiplatelet Mechanism

The ASA molecule exerts a uniquely sustained effect on the blood by irreversibly inhibiting COX-1 in circulating platelets. Because these cells lack the ability to synthesize new enzyme molecules, this mechanism causes a sustained suppression of Thromboxane A2 ( TXA2), a chemical messenger required to promote platelet aggregation.

Dosage and Administration Information

How to Use Ascriptin (Aspirin): Official Administration Guidelines

Administration of Acetylsalicylic acid (ASA), the active ingredient in Ascriptin, follows instructions detailing the proper route, dosage, and timing. The approved route for this tablet formulation is oral intake. Use is generally categorized into two patterns: intermittent, higher-frequency dosing for acute, short-term relief, and a continuous, once daily schedule for long-term supportive therapy.


Official Dosing and Frequency

Use Pattern Single Dose Range Dosing Frequency Max Duration (Self-Treatment)
Analgesia/Antipyresis 325 mg to 650 mg Every 4 or 6 hours 10 days (Pain); 3 days (Fever)
Antiplatelet Action 81 mg to 325 mg Once daily Chronic/Long-term use

For acute pain or fever, the total intake must not exceed 4000 mg in a 24-hour period.


Administration Requirements

Oral tablets must be taken with a full glass of water (approximately 8 ounces) to aid dissolution and transit. Patients should remain upright for at least 10 minutes following ingestion. A tablet may be taken with food or milk if stomach upset is experienced.

Tablets with special coatings, such as enteric-coated forms, must be swallowed whole and should not be crushed, split, or chewed. Furthermore, self-treatment with Aspirin is generally not recommended for individuals under 12 years of age. These procedural steps define the standard approach to using the medicine.

Recent Clinical Evidence

Ascriptin (Aspirin): Recent Clinical Evidence


Summary of Clinical Research

Research investigated whether Drug X is a potential therapeutic approach for frequent headaches, exploring its measured effect on pain intensity. Studies focused on adults diagnosed with specific headache types and evaluated outcomes such as the recorded number of headache days per month and overall pain scores.

A single clinical trial reported that participants who were administered Drug X was associated with a 50% decrease in the number of headache days per month in the study population. These findings contributed to the evidence base regarding the drug’s potential application in this context.

Activity Profile Explored

The research focused on the drug's activity concerning specific pain pathways. This activity was examined in relation to pain transmission. Studies in this area have been conducted to characterize the drug's measured effects on these pathways.

Study Protocol Details

The study protocol for the trials detailed the specific procedure for using the medication for participants. The participants’ pain levels and other symptoms were monitored by researchers throughout the study periods.


Safety and Tolerability Findings

Safety studies reported that Drug X was assessed for tolerability in the majority of adults in the study population. Adverse events were reported across all systems.

Specific adverse events related to cardiovascular function were reported in certain subgroups. These events were documented as part of the overall adverse event reporting in the clinical trials.

Long-term use was assessed for tolerability, and studies did not report a change in the initial effect over time. Further research is needed to determine how Drug X compares to older treatments.

Key Studies & References

  1. The effectiveness of aspirin for migraine prophylaxis: a systematic review - SciELO
  2. The mechanism of action of aspirin - PubMed Review
  3. Aspirin and heart disease: MedlinePlus Medical Encyclopedia (Safety/Side Effects)

Frequently Asked Questions (FAQ)

Common questions about Ascriptin (Aspirin) (FAQ)

Q: What makes Ascriptin's formulation different from plain aspirin pills?

A: Ascriptin is a proprietary product that contains the active ingredient, Acetylsalicylic acid (ASA), combined with buffering agents. These agents, such as magnesium or aluminum hydroxide, are intended to help rapidly neutralize stomach acid. This formulation strategy is designed to reduce the potential for stomach discomfort or irritation that may be associated with unbuffered aspirin.

Q: Does taking Ascriptin daily have any long-term effects?

A: According to official safety information, long-term or regular use of aspirin is associated with an increased risk of serious gastrointestinal adverse events, such as stomach ulceration and hemorrhage (bleeding). Additionally, continuous medication use may potentially affect organs over time. Regulatory warnings indicate that chronic use may require monitoring by a healthcare professional.

Q: How long does it typically take for Ascriptin to start working for a headache?

A: Pharmacokinetic studies indicate that for immediate-release (non-enteric-coated) aspirin formulations, the effects for pain relief typically begin to occur within 30 minutes of ingestion. The precise time to full pain relief can vary based on the individual’s physiological response.

Q: How long does the effect of one dose of Ascriptin last?

A: Based on the dosing frequency often cited for pain and fever, a single dose of aspirin is generally effective for about four to six hours. Official dosing guidelines generally reflect a frequency of every four to six hours for short-term relief.

Q: What are the most common side effects people report after taking Ascriptin?

A: Commonly reported side effects listed in official documents include minor gastrointestinal issues such as upset stomach, heartburn, and dyspepsia (indigestion). Minor gastrointestinal blood loss can also be common. Persistent or severe stomach discomfort should be discussed with a healthcare professional.

Q: Are there any foods or drinks that interact negatively with Ascriptin?

A: Official regulatory warnings emphasize that alcohol consumption must be avoided as it substantially increases the risk of gastrointestinal bleeding when combined with aspirin. Other common foods and non-alcoholic drinks are generally not listed as formal contraindications in the general labeling.

Q: Can Ascriptin be taken with Tylenol (Acetaminophen)?

A: While regulatory data does not typically list a formal, severe interaction between Acetaminophen and low-strength Aspirin, caution is always recommended when combining multiple pain-relieving medications. Reviewing your full medication list with a healthcare provider is generally recommended when combining over-the-counter products.

Q: What happens if I take Ascriptin with other NSAIDs like Ibuprofen?

A: Official safety documents strictly state that concomitant use with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as Ibuprofen, is documented to significantly increase the risk of gastrointestinal ulcers and bleeding. Official labeling notes that timing separation may be required for occasional Ibuprofen use to avoid interference with aspirin’s antiplatelet effect.

Q: Why is it recommended to take Ascriptin with food?

A: Official guidance suggests taking aspirin with food, milk, or a full glass of water. This is intended to mitigate stomach irritation and aid the dissolution of the tablet, helping to lessen the potential for gastrointestinal discomfort.

Q: Is Ascriptin the same thing as enteric-coated aspirin?

A: Ascriptin is defined as a buffered aspirin formulation. Enteric-coated aspirin is a different type of formulation that uses a special coating to prevent it from dissolving until it reaches the small intestine. While some products can be both, Ascriptin is primarily known for its buffered feature.

Q: What is the recommended storage temperature for Ascriptin?

A: Ascriptin should be kept at room temperature, which typically means avoiding excessive heat (above 40 C or 104 F). The product must also be stored in its original container, tightly closed, and protected from moisture to prevent deterioration.

Q: How should I dispose of expired Ascriptin tablets?

A: The FDA recommends disposing of unused or expired medication through an authorized drug take-back program if one is available. If a program is not accessible, the medication can be mixed with an unappealing substance, sealed in a plastic bag, and discarded in household trash.

Q: Is it normal to have a mild indigestion feeling after taking Ascriptin?

A: Yes, mild indigestion or dyspepsia is listed as a common adverse reaction associated with aspirin use. While common, this feeling may signal some stomach irritation. If this feeling is persistent or severe, it should be discussed with a healthcare professional.

Q: Does Ascriptin interact with common herbal supplements?

A: While specific herbal supplements may not be listed in all regulatory documents, safety information advises caution. Certain herbal products can potentially increase the risk of bleeding and should be reviewed with a healthcare professional prior to co-administration with aspirin.

Q: Why do people sometimes crush or chew Aspirin, and is that safe with Ascriptin?

A: Official regulatory guidance explicitly states that buffered or coated tablets must be swallowed whole and should not be crushed, split, or chewed. Crushing the tablet may compromise the specialized formulation and could potentially increase the risk of gastrointestinal irritation.

Q: Can Ascriptin affect kidney function?

A: Aspirin is known to affect renal function and is officially contraindicated in patients with severe renal insufficiency (kidney failure). Use in individuals with pre-existing kidney conditions is designated as a cautionary use, which generally involves professional medical guidance.

Q: What is the scientific mechanism behind Ascriptin's action?

A: The active ingredient, Acetylsalicylic acid (ASA), works by irreversibly deactivating Cyclooxygenase (COX) enzymes throughout the body. This blocks the synthesis of chemical messengers: Prostaglandins (reducing pain and fever) and Thromboxane A2 (reducing the ability of platelets to clump together for its antiplatelet effect).

Q: Does Ascriptin interact with common antidepressants?

A: Official regulatory documents indicate that co-administration with certain types of antidepressants, specifically Selective Serotonin Reuptake Inhibitors (SSRIs), is documented to increase the risk of bleeding. This potential interaction is generally recommended to be reviewed by a healthcare provider.

Q: Why are people with asthma sometimes advised against taking Aspirin?

A: The medicine is contraindicated in patients with a history of hypersensitivity to NSAIDs. Since aspirin can cause serious adverse reactions, including bronchospasm (narrowing of the airways), patients with pre-existing asthma or nasal polyps are often considered at a heightened risk for such reactions.

Q: Can Ascriptin cause dizziness or lightheadedness?

A: Yes, dizziness is listed as a potential side effect in adverse reaction reports. The sensation of drowsiness has also been reported. The side effect profile indicates that if dizziness or lightheadedness occurs, caution is generally advised.

Q: Can Ascriptin be used to treat arthritis pain?

A: Aspirin is generally indicated for the relief of minor pain and possesses anti-inflammatory properties. While historical data exists, the appropriate use and dosing regimen for chronic conditions like arthritis must be determined by a healthcare professional.

Q: How soon before a minor surgery should you stop taking Ascriptin?

A: Due to its irreversible action on blood platelets, aspirin's effect on increased bleeding time persists for approximately four to eight days after the last dose. Official safety information generally requires that aspirin use be discontinued before upcoming surgical or dental procedures.

Q: Does taking Ascriptin regularly increase the risk of bleeding?

A: Yes, regulatory safety documents confirm that the risk of serious side effects, particularly gastrointestinal bleeding, is documented to increase with the duration of use of aspirin.

Q: Why is Ascriptin included in some multi-symptom cold medications?

A: Aspirin is included in some combination cold formulations because of its established classification and use as an antipyretic (to help reduce fever) and an analgesic (to help relieve minor body aches and pains associated with the cold or flu).

Q: Can Ascriptin affect sleep?

A: Adverse event reporting sometimes includes drowsiness as a potential side effect of aspirin. However, the exact impact on the sleep cycle, such as causing insomnia, is not consistently detailed in all general regulatory documents.

Q: Is there a risk of overuse with Ascriptin for chronic pain?

A: Yes, for the self-treatment of pain, official guidelines typically limit the duration to 10 days and specify a total daily intake that must not be exceeded. Exceeding these limits increases the risk of serious side effects, including gastrointestinal issues and potential overdose.

How should Ascriptin (Aspirin) be stored and disposed of?

How to Store and Dispose of Ascriptin (Aspirin)?

Storage Requirements

Condition Requirement
Temperature Store at room temperature. Avoid excessive heat (above 40 C or 104 F).
Protection Keep in the original container, tightly closed, away from excess moisture and light (do not store in the bathroom).
Stability Check Discard tablets immediately if they develop a strong, vinegar-like smell, which indicates deterioration.
Child Safety Keep this medication out of the sight and reach of children and pets.

Disposal Instructions

Dispose of unused or expired medication using an authorized drug take-back program. If a take-back program is unavailable, mix the medicine (do not crush) with an unappealing substance, such as dirt or cat litter, place the mixture into a sealed plastic bag, and discard it in the household trash. Do not flush this medication down the toilet unless explicitly instructed to do so by regulatory guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ascriptin (Aspirin) found in:

A-Z Index: